None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: • EVERY PATIENT TO BE INCLUDED IN THIS STUDY IS OVER 12 MONTHS AND UNDER 5 YEARS (60 MONTHS) OF AGE, WITH THIS PICTURE OF MILD DYSENTERY (AQUEOUS DIARRHEA WITH FEVER AND PRESENCE OF RED CELLS AND PLATELETS> 50 FOR FIELD) OR MODERATE DYSENTERY 72hrs OR LESS DURATION AND GO TO BE ATTENDED IN HOSPITALS SELECTED FOR THE STUDY.
Exclusion criteria
Exclusion criteria: • CHILDREN WITH A PREVIOUS DIAGNOSIS OF CONDITIONS TO BE CONSIDERED CONTRAINDICATIONS FOR TREATMENT WITH FURAZOLIDONE, SUCH AS LACK OF GLUCOSE 6 PHOSPHATE DEHYDROGENASE, HEMOLYTIC ANEMIA RELATED TO G6PD AND KINASE PYRUVATE DEFICIENCY. • CHILDREN COMORBIDITIES BACKGROUND AFFECTING THE IMMUNE STATE AND THEN THE CLINIC (INFECTION WITH HIV, AIDS; CHRONIC DISEASES: LIVER, KIDNEY, HEART, KIDNEY FAILURE, SEVERE MALNUTRITION). • CHILDREN KNOW THAT HAS RECEIVED DIPHENOXYLATE HYDROCHLORIDE THERAPY WITH ATROPINE OR LOPERAMIDE, BECAUSE OF THE RISK OF EXTENDING DISEASE. • CHILDREN WITH PRIOR ALLERGIC OR HYPERSENSITIVITY TO FLUOROQUINOLONES OR OTHER DERIVATIVES OF QUINOLONES. • CHILDREN WITH TENDINITIS BACKGROUND OR BREACH OF TENDON, CENTRAL NERVOUS SYSTEM DISORDERS INCLUDING CEREBRAL ATHEROSCLEROSIS, EPILEPSY, OR OTHER FACTORS THAT PREDISPOSE TO SEIZURE. • CHILDREN THAT HAVE RECEIVED ANY DOSE OF ANTIBIOTICS IN THE LAST 72 HOURS DURING THE CURRENT CLINICAL CONDITION. • PATIENTS WHOSE PARENTS refuse to PARTICIPATE IN THE STUDY OR NOT SIGN THE INFORMED CONSENT.
Countries
France
Contacts
UNIVERSIDAD PERUANA CAYETANO HEREDIA